Skip to main content
. 2021 Oct 22;12:727171. doi: 10.3389/fneur.2021.727171

Table 1.

Characteristics of patients included in the derivation and validation set.

Derivation set (n = 297) Validation set (n = 160)
Age, mean (SD) 65.6 (15.3) 68.9 (13.2)
Sex (female), n (%) 143 (48.1%) 82 (51.2%)
Hypertension, n (%) 198 (66.7%) 126 (78.8%)
Diabetes mellitus, n (%) 64 (21.5%) 43 (26.9%)
History of stroke or TIA, §n (%) 43 (14.5%) 20 (12.5%)
History of atrial fibrillation, n (%) 97 (32.7%) 53 (33.1%)
Hemorrhagic transformation||
None, n (%) 121 (40.7%) 83 (51.9%)
   Hemorrhage infarction type 1 (HI1), n (%) 58 (19.5%) 34 (21.2%)
   Hemorrhage infarction type 2 (HI2), n (%) 51 (17.2%) 27 (16.9%)
   Parenchymal hematoma type 1 (PH1), n (%) 43 (14.5%) 8 (5.0%)
   Parenchymal hematoma type 2 (PH2), n (%) 23 (7.7%) 8 (5.0%)
NIHSS score at discharge, median (IQR) 6 (2–14) 8 (3–16)
Infarct volume at early follow up, ** median (IQR) 26.2 (10.6–67.5) 37.7 (22.5–89.9)
Premorbid mRS, median (IQR) 0 (0–0) 0 (0–0)

p = 0.02;

p = 0.01;

§

missing value: derivation set (n = 1);

||

p = 0.01, graded per European cooperative acute stroke study criteria, missing value: derivation set (n = 1);

p = 0.03;

**

missing values: derivation set (n = 44), p < 0.001.

Wilcoxon rank-sum test for age; Fisher's exact test for sex, hypertension, history of stroke or TIA, history of smoking, and history of atrial fibrillation.